Results 11 to 20 of about 1,238,265 (360)

Metastatic esophageal carcinosarcoma comprising neuroendocrine carcinoma, squamous cell carcinoma, and sarcoma: A case report. [PDF]

Medicine (Baltimore), 2018
Rationale: Esophageal carcinosarcoma generally comprises 2 histological components: squamous cell carcinoma (SqCC) and sarcoma. Esophageal carcinosarcoma comprising 3 components is extremely rare and no reports have described therapeutic effects for this
Tsuchihashi K, Arita S, Fujiwara M, Iwasaki K, Hirano A, Yoshihiro T, Nio K, Koga Y, Esaki M, Ariyama H, Kusaba H, Moriyama T, Ohuchida K, Nagai E, Nakamura M, Oda Y, Akashi K, Baba E.   +17 more
europepmc   +2 more sources

A proteogenomic portrait of lung squamous cell carcinoma

Cell, 2021
Summary Lung squamous cell carcinoma (LSCC) remains a leading cause of cancer death with few therapeutic options. We characterized the proteogenomic landscape of LSCC, providing a deeper exposition of LSCC biology with potential therapeutic implications.
Christopher R Kinsinger, Ana I Robles, David Fenyö   +2 more
exaly   +2 more sources

Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma

Cell, 2020
Summary To define the cellular composition and architecture of cutaneous squamous cell carcinoma (cSCC), we combined single-cell RNA sequencing with spatial transcriptomics and multiplexed ion beam imaging from a series of human cSCCs and matched normal ...
Sizun Jiang, Annelie Mollbrink, Margaret Guo   +2 more
exaly   +2 more sources

seed lectin inhibits oral squamous cell carcinoma tumorigenesis by suppressing N6-methyladenosine modification–mediated SRY-box transcription factor 2 expression [PDF]

Journal of International Medical Research
Objective Studies have indicated that combining Maackia amurensis seed lectin with first-line chemotherapeutic agents enhances the efficacy of treatment for oral squamous cell carcinoma.
Yong Du, Haiyan Yang, Hongguang Lian, Dan Li, Weina Liu, Linyuan Zhao, Yufeng Zhang   +6 more
doaj   +2 more sources

Cutaneous Squamous Cell Carcinoma

Hematology/Oncology Clinics of North America, 2019
Cutaneous squamous cell carcinoma represents 20% of all skin cancers, resulting in 1 million cases in the United States each year. The lifetime risk of developing squamous cell carcinoma continues to increase annually and will likely continue to increase
Chrysalyne Schmults
exaly   +2 more sources

Beyond Squamous Cell Carcinoma: Basaloid Squamous Cell Carcinoma of the Esophagus [PDF]

Cureus, 2021
Basaloid squamous cell carcinoma (BSCC) is a poorly differentiated variant of squamous cell carcinoma (SCC) with distinct morphologic characteristics. Yet, there are no clearly defined guidelines established for management. BSCC in the esophagus is a very rare entity, with the proportion of esophageal BSCC ranging from 0.068% to 11%. This wide range is
Song, Heeyah, Tetangco, Eula, Ton, Loc, Barrett, Amanda, Yap, John Erikson L   +4 more
openaire   +2 more sources

Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma

Medical Science, 2023
Head and neck squamous cell carcinoma (HNSCC) is a group of malignancies, involving the oral cavity, pharynx, hypopharynx, larynx, nasal cavity, and salivary glands, that together compose the seventh most common cancer diagnosis worldwide.
Adam Barsouk, J. Aluru, Prashanth Rawla, Kalyan Saginala, Alexander Barsouk   +4 more
semanticscholar   +1 more source

Head and neck squamous cell carcinoma

Nature Reviews Disease Primers, 2020
Head and neck squamous cell carcinomas (HNSCCs) originate from the mucosal epithelium in the oral cavity, pharynx and larynx, and are caused by viral infection or carcinogen exposure.
Daniel E. Johnson, B. Burtness, C. Leemans, V. Lui, J. Bauman, J. Grandis   +5 more
semanticscholar   +2 more sources

Clinical and Paraclinical Characteristics of Endobronchial Pulmonary Squamous Cell Carcinoma—A Brief Review

Diagnostics, 2023
Background: Endobronchial squamous cell carcinoma is one of the most common types of tumors located inside the tracheobronchial tree. Patients often present in advanced stages of the disease, which most often leads to a targeted therapeutic attitude of ...
Radu Serban Matache, Camelia Stanciu-Gavan, Daniel Pantile, Adrian Mihail Iordache, Andreea Octavia Bejgăneanu, Crenguța Sorina Șerboiu, Alexandra Floriana Nemes   +6 more
doaj   +1 more source

Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma.

New England Journal of Medicine, 2022
BACKGROUND First-line chemotherapy for advanced esophageal squamous-cell carcinoma results in poor outcomes. The monoclonal antibody nivolumab has shown an overall survival benefit over chemotherapy in previously treated patients with advanced esophageal
Y. Doki, J. Ajani, Ken Kato, Jianming Xu, L. Wyrwicz, S. Motoyama, T. Ogata, H. Kawakami, Chih-Hung Hsu, A. Adenis, F. El hajbi, M. Di Bartolomeo, M. Braghiroli, E. Holtved, S. A. Ostoich, H. R. Kim, Masaki Ueno, Wasat Mansoor, Wen-Chi Yang, Tianshu Liu, J. Bridgewater, T. Makino, I. Xynos, Xuan Liu, M. Lei, K. Kondo, Apurva Patel, J. Gricar, I. Chau, Y. Kitagawa   +29 more
semanticscholar   +1 more source